Impact of Phase 2b strategies on optimization of drug development programs

Christopher Jennison; Zoran Antonijevic; Jim Bolognese; Carl-Fredrik Burman; Christy Chuang-Stein; Martin Kimber; Olga Marchenko; Nitin Patel; Jose Pinheiro

doi:10.1007/978-3-319-09075-7_6

Impact of Phase 2b strategies on optimization of drug development programs

Christopher Jennison, Zoran Antonijevic, Jim Bolognese, Carl-Fredrik Burman, Christy Chuang-Stein, Martin Kimber, Olga Marchenko, Nitin Patel, Jose Pinheiro

Research output: Chapter or section in a book/report/conference proceeding › Book chapter

Original language	English
Title of host publication	Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy
Place of Publication	Heidelberg
Publisher	Springer
Pages	83-103
ISBN (Electronic)	978-3-319-09075-7
ISBN (Print)	978-3-319-09074-0
DOIs	https://doi.org/10.1007/978-3-319-09075-7_6
Publication status	Published - 2015

Access to Document

10.1007/978-3-319-09075-7_6

Cite this

Jennison, C., Antonijevic, Z., Bolognese, J., Burman, C.-F., Chuang-Stein, C., Kimber, M., Marchenko, O., Patel, N., & Pinheiro, J. (2015). Impact of Phase 2b strategies on optimization of drug development programs. In Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy (pp. 83-103). Springer. https://doi.org/10.1007/978-3-319-09075-7_6

Jennison, C, Antonijevic, Z, Bolognese, J, Burman, C-F, Chuang-Stein, C, Kimber, M, Marchenko, O, Patel, N & Pinheiro, J 2015, Impact of Phase 2b strategies on optimization of drug development programs. in Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy. Springer, Heidelberg, pp. 83-103. https://doi.org/10.1007/978-3-319-09075-7_6

@inbook{75598c9ffd324102a538a841f047ae52,

title = "Impact of Phase 2b strategies on optimization of drug development programs",

author = "Christopher Jennison and Zoran Antonijevic and Jim Bolognese and Carl-Fredrik Burman and Christy Chuang-Stein and Martin Kimber and Olga Marchenko and Nitin Patel and Jose Pinheiro",

year = "2015",

doi = "10.1007/978-3-319-09075-7\_6",

language = "English",

isbn = "978-3-319-09074-0",

pages = "83--103",

booktitle = "Optimization of Pharmaceutical R\&D Programs and Portfolios: Design and Investment Strategy",

publisher = "Springer",

}

TY - CHAP

T1 - Impact of Phase 2b strategies on optimization of drug development programs

AU - Jennison, Christopher

AU - Antonijevic, Zoran

AU - Bolognese, Jim

AU - Burman, Carl-Fredrik

AU - Chuang-Stein, Christy

AU - Kimber, Martin

AU - Marchenko, Olga

AU - Patel, Nitin

AU - Pinheiro, Jose

PY - 2015

Y1 - 2015

UR - http://dx.doi.org/10.1007/978-3-319-09075-7_6

UR - https://www.scopus.com/pages/publications/84944049954

U2 - 10.1007/978-3-319-09075-7_6

DO - 10.1007/978-3-319-09075-7_6

M3 - Book chapter

SN - 978-3-319-09074-0

SP - 83

EP - 103

BT - Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

PB - Springer

CY - Heidelberg

ER -

Impact of Phase 2b strategies on optimization of drug development programs

Access to Document

Other files and links

Cite this